Fusion event
HBV-chr22 integration
Disease
Hepatocellular carcinoma (HCC)
Quality evaluation
Normal
Integrated sequence
TAAGAGGACTCTTGGACTCTCAGCAATGTCAACGACCGACCTTGAGGCATACTTCAAAGACTGTTTGTTTAAAGACTGGGAGGAGTTGGGGGAGGAGATT| |AGGTTAAAGGTCTTTGTACTAGGAGGCTGTAGGCATAAATTGGTCTGCGCACCAGCACCATGCAACTTTTTCACCTCTGCCTAATCATCTCTTGTTCATG
End
48777382/48381570 (Hg38)
Nearest miRNA
hsa-let-7a-3/Upstream/107155; hsa-mir-12114/Downstream/398725;
Upstream sequence
ACCCAGGGTACAGCAGACTCAGGATGCAATAGACCCAGGGTACAACAGACCCAGGACACAAGAGACCCAGGGGACAACCAACCCAGGAGACAATCGACCC
Downstream sequence
AGGGTACAACAGACTCAGGATGCGATAGACCCAGGGTACAACAGACCCAGGACACAAGAGACCCAGGGGACAACCAACCCAGGAGACAATCGACCCAGGG
Yang, L., et al. Molecular Characterization of HBV DNA Integration in Patients with Hepatitis and Hepatocellular Carcinoma. J Cancer ,2018,9(18): 3225-3235.